Trivitron Healthcare, a medical technology company has forged a JV with the Italy based DiaSorin Group to enter the immuno diagnostics market.
In the JV company - DiaSorin Trivitron Healthcare – Trivitron will be holding a 49 per cent stake. Immuno diagnostics involves lab detection and testing of infectious diseases (viral and bacterial) and vitamin D deficiency at the minute, nano gram level. While Trivitron will commence with imports from January 2013, it eventually wants to manufacture the device at its technology park near Chennai.